Texas Psychedelic Legislation

5 psychedelic policy bills tracked in Texas, covering Ibogaine, Psilocybin. Current status breakdown: In Committee (3), Passed Legislature (1), Passed Committee (1).

Texas psychedelic bills

Bill	State	Substance	Type	Status	Sponsor	Last action
SB2308 - Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment.	Texas	Ibogaine	Clinical Research	Passed Legislature	Tan Parker	Jun 11, 2025
HB4014 - Relating to a study on the use of psychedelic therapies in the treatment of certain conditions.	Texas	Psilocybin	Therapeutic Access	In Committee	John Bucy	May 19, 2025
HB3717 - Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.	Texas	Ibogaine	Therapeutic Access	Passed Committee	Cody Harris	May 12, 2025
SB3005 - Relating to a study on the use of psychedelic therapies in the treatment of certain conditions.	Texas	Psilocybin	Therapeutic Access	In Committee	Cesar Blanco	Apr 29, 2025
HB4423 - Relating to the establishment of the Psilocybin Research Advisory Council.	Texas	Psilocybin	Clinical Research	In Committee	Josey Garcia	Mar 21, 2023

All states · Full psychedelic legislation tracker